Cultures were established in a 96-well microculture format to favor stimulation of rare peptide-dependent minor histocompatibility antigens (mHAg)- or tumor antigen-specific CTLs instead of allo-HLA-B or -HLA-C mismatch reactions, which would dominate in bulk MLTC. The gene discussed is HLA-B; the disease is neoplasm.